Product Name

  • Name

    Mitomycin C

  • EINECS 200-008-6
  • CAS No. 50-07-7
  • Article Data28
  • CAS DataBase
  • Density 1.564 g/cm3
  • Solubility soluble in water
  • Melting Point 360 °C
  • Formula C15H18N4O5
  • Boiling Point 581.78 °C at 760 mmHg
  • Molecular Weight 334.332
  • Flash Point 305.65 °C
  • Transport Information UN 3462 6.1/PG 2
  • Appearance dark blue grey crystalline powder
  • Safety 36/37-45-28A-28-53-22
  • Risk Codes 25-40-22-45-26/27/28
  • Molecular Structure Molecular Structure of 50-07-7 (Mitomycin C)
  • Hazard Symbols ToxicT,HarmfulXn,VeryT+
  • Synonyms Azirino[2',3':3,4]pyrrolo[1,2-a]indole-4,7-dione,6-amino-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methyl-,(1aS,8S,8aR,8bS)-;Mitomycin C (6CI,7CI);Ametycine;MMC;MitoExtra;Mitomycin;Mitonco;Mitoplus;Mytomycin Kyowa S;NSC26980;Mito-C;A0049 1,4-Dihydroxy-2-tetraprenylbenzene derivative;
  • PSA 146.89000
  • LogP 0.01610

Synthetic route

albomitomycin A
110934-24-2

albomitomycin A

mitomycin C
50-07-7

mitomycin C

Conditions
ConditionsYield
With ammonia at 25℃; for 0.5h;99%
Multi-step reaction with 2 steps
1: 1) H2, 2) air / 1) 10percent Pd on carbon / 1) acetonitrile, 1 atm, 25 deg C, 2 h, 2) 25 deg C, 2 h
2: 75 percent / 6 M methanol. NH3 / 5 h / 25 °C
View Scheme
2-((2-(piperidin-1-yl)ethyl)disulfanyl)ethyl(1aS,8S,8aR,8bS)-6-amino-8-((carbamoyloxy)methyl)-8a-methoxy-5-methyl-4,7-dioxo-1a,4,7,8,8a,8b-hexahydroazirino [2’,3’:3,4]pyrrolo[1,2-a]indole-1(2H)-carboxylate

2-((2-(piperidin-1-yl)ethyl)disulfanyl)ethyl(1aS,8S,8aR,8bS)-6-amino-8-((carbamoyloxy)methyl)-8a-methoxy-5-methyl-4,7-dioxo-1a,4,7,8,8a,8b-hexahydroazirino [2’,3’:3,4]pyrrolo[1,2-a]indole-1(2H)-carboxylate

mitomycin C
50-07-7

mitomycin C

Conditions
ConditionsYield
With l-cysteine hydrochloride In ethanol; water at 37℃; for 2h;92%
1a-acetyl-7-demethoxy-6,7-dihydro-7,7-(ethylenedioxy)-6-(phenylselenyl)mitomycin A
122644-74-0, 122675-60-9, 134679-23-5

1a-acetyl-7-demethoxy-6,7-dihydro-7,7-(ethylenedioxy)-6-(phenylselenyl)mitomycin A

mitomycin C
50-07-7

mitomycin C

Conditions
ConditionsYield
With ammonia; dimedone In methanol Ambient temperature;81%
7-O-(2',3',4',6'-tetra-O-acetyl-β-D-glucopyranosyl)-9a-methoxymitosane
128583-70-0

7-O-(2',3',4',6'-tetra-O-acetyl-β-D-glucopyranosyl)-9a-methoxymitosane

mitomycin C
50-07-7

mitomycin C

Conditions
ConditionsYield
With ammonium hydroxide In methanol for 0.5h; Ambient temperature;80%
isomitomycin A
91917-64-5

isomitomycin A

mitomycin C
50-07-7

mitomycin C

Conditions
ConditionsYield
With ammonia at 25℃; for 5h;75%
7-<<(dimethylamino)methylene>amino>-N10-<(dimethylamino)methylene>-9a-methoxymitosane
88948-91-8

7-<<(dimethylamino)methylene>amino>-N10-<(dimethylamino)methylene>-9a-methoxymitosane

Benzhydrylamine
91-00-9

Benzhydrylamine

A

mitomycin C
50-07-7

mitomycin C

B

7-<<(dimethylamino)methylene>amino>-9a-methoxymitosane
88949-01-3

7-<<(dimethylamino)methylene>amino>-9a-methoxymitosane

C

7-<(diphenylmethyl)amino>-9a-methoxymitosane
110971-78-3

7-<(diphenylmethyl)amino>-9a-methoxymitosane

Conditions
ConditionsYield
In methanol at 54℃; for 4h;A 20%
B 41%
C 8%
2-(2-Pyridinyldithio)benzylmitomycin C-1a-carboxylate
126900-78-5

2-(2-Pyridinyldithio)benzylmitomycin C-1a-carboxylate

mitomycin C
50-07-7

mitomycin C

Conditions
ConditionsYield
With diothiothreitol In methanol; water at 30℃; pH 7.2; other (2-pyridinyldithio)benzyl MMC-1a-carboxylates;
7-<<(dimethylamino)methylene>amino>-9a-methoxymitosane
88949-01-3

7-<<(dimethylamino)methylene>amino>-9a-methoxymitosane

mitomycin C
50-07-7

mitomycin C

Conditions
ConditionsYield
With phsphate buffer In water at 45℃; Rate constant; Mechanism; pH 6.5, other pH, other buffer, other temperature;
leucomitomycin C
92056-69-4

leucomitomycin C

mitomycin C
50-07-7

mitomycin C

Conditions
ConditionsYield
With oxygen In ethanol
C15H18N4O6

C15H18N4O6

mitomycin C
50-07-7

mitomycin C

Conditions
ConditionsYield
With methanol; water at 20℃; Irradiation;
C19H26N4O6

C19H26N4O6

mitomycin C
50-07-7

mitomycin C

Conditions
ConditionsYield
With methanol; water at 20℃; Irradiation;
C16H20N4O6

C16H20N4O6

mitomycin C
50-07-7

mitomycin C

Conditions
ConditionsYield
With methanol; water at 20℃; Irradiation;
With water In methanol; ethyl acetate Mechanism; Irradiation; other mitomycin C derivatives;
(8aS)-8a-bromoalbomitomycin A
132732-87-7, 132830-44-5

(8aS)-8a-bromoalbomitomycin A

mitomycin C
50-07-7

mitomycin C

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 85 percent / tributyltin hydride, AIBN / toluene / 0.17 h / 60 °C
2: 99 percent / 6 M methanol. NH3 / 0.5 h / 25 °C
View Scheme
Multi-step reaction with 3 steps
1: 85 percent / tributyltin hydride, AIBN / toluene / 0.17 h / 60 °C
2: 1) H2, 2) air / 1) 10percent Pd on carbon / 1) acetonitrile, 1 atm, 25 deg C, 2 h, 2) 25 deg C, 2 h
3: 75 percent / 6 M methanol. NH3 / 5 h / 25 °C
View Scheme
(8aR)-8a-bromoalbomitomycin A
132732-87-7, 132830-44-5

(8aR)-8a-bromoalbomitomycin A

mitomycin C
50-07-7

mitomycin C

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 54 percent / H2, NaHCO3 / 5percent Pd on BaSO4 / methanol; H2O / 0.17 h / 25 °C
2: 99 percent / 6 M methanol. NH3 / 0.5 h / 25 °C
View Scheme
Multi-step reaction with 3 steps
1: 54 percent / H2, NaHCO3 / 5percent Pd on BaSO4 / methanol; H2O / 0.17 h / 25 °C
2: 1) H2, 2) air / 1) 10percent Pd on carbon / 1) acetonitrile, 1 atm, 25 deg C, 2 h, 2) 25 deg C, 2 h
3: 75 percent / 6 M methanol. NH3 / 5 h / 25 °C
View Scheme
Multi-step reaction with 3 steps
1: K2CO3 / acetonitrile / 24 h / 25 °C
2: 85 percent / tributyltin hydride, AIBN / toluene / 0.17 h / 60 °C
3: 99 percent / 6 M methanol. NH3 / 0.5 h / 25 °C
View Scheme
Multi-step reaction with 4 steps
1: K2CO3 / acetonitrile / 24 h / 25 °C
2: 85 percent / tributyltin hydride, AIBN / toluene / 0.17 h / 60 °C
3: 1) H2, 2) air / 1) 10percent Pd on carbon / 1) acetonitrile, 1 atm, 25 deg C, 2 h, 2) 25 deg C, 2 h
4: 75 percent / 6 M methanol. NH3 / 5 h / 25 °C
View Scheme
CHCl3-MeOH

CHCl3-MeOH

mitomycin A
4055-39-4

mitomycin A

mitomycin C
50-07-7

mitomycin C

C256H490N4O123S2

C256H490N4O123S2

A

carbon dioxide
124-38-9

carbon dioxide

B

4-mercaptobenzyl alcohol
53339-53-0

4-mercaptobenzyl alcohol

C

mPEG5000-SH

mPEG5000-SH

D

mitomycin C
50-07-7

mitomycin C

Conditions
ConditionsYield
With N-acetylcystein at 37℃; pH=4.5; Kinetics; pH-value;
methyl chlorodithioformate
16696-91-6

methyl chlorodithioformate

mitomycin C
50-07-7

mitomycin C

7-amino-9a-methoxy-1a-<(methylthio)thiocarbonyl>mitosane
109334-26-1

7-amino-9a-methoxy-1a-<(methylthio)thiocarbonyl>mitosane

Conditions
ConditionsYield
With triethylamine In 1,2-dimethoxyethane at 80℃; for 1h;95%
phenyl chlorothioformate
13464-19-2

phenyl chlorothioformate

mitomycin C
50-07-7

mitomycin C

7-amino-9a-methoxy-1a-<(phenylthio)carbonyl>mitosane
109334-21-6

7-amino-9a-methoxy-1a-<(phenylthio)carbonyl>mitosane

Conditions
ConditionsYield
With triethylamine In 1,2-dimethoxyethane at 45℃; for 1h;95%
mitomycin C
50-07-7

mitomycin C

trifluoroacetic acid
76-05-1

trifluoroacetic acid

A

1β-hydroxy-2β-trifluoroacetamido-7-aminomitosene
111602-68-7

1β-hydroxy-2β-trifluoroacetamido-7-aminomitosene

B

Carbamic acid (1R,2S)-2-acetylamino-7-amino-1-hydroxy-6-methyl-5,8-dioxo-2,3,5,8-tetrahydro-1H-pyrrolo[1,2-a]indol-9-ylmethyl ester
55253-24-2

Carbamic acid (1R,2S)-2-acetylamino-7-amino-1-hydroxy-6-methyl-5,8-dioxo-2,3,5,8-tetrahydro-1H-pyrrolo[1,2-a]indol-9-ylmethyl ester

Conditions
ConditionsYield
With urethane Mechanism; Product distribution; multistep;A 95%
B 5%
With urethane 1.) MeCN, RT; Yield given. Multistep reaction;A n/a
B 5%
(4-nitrophenyl) [4-(2-pyridyldisulfanyl)phenyl]methyl carbonate
1151989-04-6

(4-nitrophenyl) [4-(2-pyridyldisulfanyl)phenyl]methyl carbonate

mitomycin C
50-07-7

mitomycin C

4-(2-Pyridinyldithio)benzylmitomycin C-1a-carboxylate
126900-80-9

4-(2-Pyridinyldithio)benzylmitomycin C-1a-carboxylate

Conditions
ConditionsYield
With dmap In N,N-dimethyl-formamide at 0 - 20℃; for 5h; Inert atmosphere;95%
With dmap In N,N-dimethyl-formamide at 20℃;83%
mitomycin C
50-07-7

mitomycin C

methyl thiochloroformate
18369-83-0

methyl thiochloroformate

7-amino-9a-methoxy-1a-<(methylthio)carbonyl>mitosane
109334-22-7

7-amino-9a-methoxy-1a-<(methylthio)carbonyl>mitosane

Conditions
ConditionsYield
With triethylamine In 1,2-dimethoxyethane at 45℃; for 1h;94%
mitomycin C
50-07-7

mitomycin C

phenyl isocyanate
103-71-9

phenyl isocyanate

7-amino-9a-methoxy-1a-(phenylcarbamoyl)mitosane
109334-19-2

7-amino-9a-methoxy-1a-(phenylcarbamoyl)mitosane

Conditions
ConditionsYield
In 1,2-dimethoxyethane at 45℃; for 1h;92%
mitomycin C
50-07-7

mitomycin C

10-decarbamoyl mitomycin C
26909-37-5

10-decarbamoyl mitomycin C

Conditions
ConditionsYield
With sodium methylate In methanol; benzene for 48h; Ambient temperature;90%
With sodium methylate In methanol; benzene for 12h; Ambient temperature;80%
With sodium methylate In methanol; benzene80%
With sodium methylate In toluene80%
glutaric anhydride,
108-55-4

glutaric anhydride,

mitomycin C
50-07-7

mitomycin C

1a-(4-carboxybutyryl)-mitomycin C

1a-(4-carboxybutyryl)-mitomycin C

Conditions
ConditionsYield
In tetrahydrofuran at 60℃; for 10h; Acylation;90%
mitomycin C
50-07-7

mitomycin C

phenyl chloroformate
1885-14-9

phenyl chloroformate

7-amino-9a-methoxy-1a-(phenoxycarbonyl)mitosane
109334-17-0

7-amino-9a-methoxy-1a-(phenoxycarbonyl)mitosane

Conditions
ConditionsYield
With triethylamine In 1,2-dimethoxyethane at 45℃; for 1h;89%
methanol
67-56-1

methanol

mitomycin C
50-07-7

mitomycin C

1a-acetyl-7-demethoxy-6,7-dihydro-7,7-(ethylenedioxy)mitomycin A
119411-13-1

1a-acetyl-7-demethoxy-6,7-dihydro-7,7-(ethylenedioxy)mitomycin A

Conditions
ConditionsYield
With ammonia88%
phenyl chlorodithioformate
16911-89-0

phenyl chlorodithioformate

mitomycin C
50-07-7

mitomycin C

7-amino-9a-methoxy-1a-<(phenylthio)thiocarbonyl>mitosane
109334-25-0

7-amino-9a-methoxy-1a-<(phenylthio)thiocarbonyl>mitosane

Conditions
ConditionsYield
With triethylamine In 1,2-dimethoxyethane at 70℃; for 3h;88%
mitomycin C
50-07-7

mitomycin C

methyl chloroformate
79-22-1

methyl chloroformate

7-amino-9a-methoxy-1a-(methoxycarbonyl)mitoane
109334-18-1

7-amino-9a-methoxy-1a-(methoxycarbonyl)mitoane

Conditions
ConditionsYield
With triethylamine In 1,2-dimethoxyethane at 45℃; for 1h;88%
mitomycin C
50-07-7

mitomycin C

methyl isocyanate
624-83-9

methyl isocyanate

7-amino-9a-methoxy-1a-(methylcarbamoyl)mitosane
109334-20-5

7-amino-9a-methoxy-1a-(methylcarbamoyl)mitosane

Conditions
ConditionsYield
In 1,2-dimethoxyethane at 45℃; for 1h;86%
mitomycin C
50-07-7

mitomycin C

phenylcarbonochloridothioate
1005-56-7

phenylcarbonochloridothioate

7-amino-9a-methoxy-1a-(phenoxythiocarbonyl)mitosane
109334-23-8

7-amino-9a-methoxy-1a-(phenoxythiocarbonyl)mitosane

Conditions
ConditionsYield
With triethylamine In 1,2-dimethoxyethane at 45℃; for 1h;85%
mitomycin C
50-07-7

mitomycin C

mitomycin A
4055-39-4

mitomycin A

Conditions
ConditionsYield
With potassium hydroxide In methanol84%
mitomycin C
50-07-7

mitomycin C

7-hydroxy-9a-methoxymitosane
7041-61-4

7-hydroxy-9a-methoxymitosane

Conditions
ConditionsYield
With sodium hydroxide at 20℃; for 4h;84%
With alkaline solution In water Kinetics;
mitomycin C
50-07-7

mitomycin C

methanesulfonyl chloride
124-63-0

methanesulfonyl chloride

N(1a)-(methanesulfonyl)mitomycin C
5091-31-6

N(1a)-(methanesulfonyl)mitomycin C

Conditions
ConditionsYield
With pyridine; triethylamine at 0℃; for 0.333333h;80%
mitomycin C
50-07-7

mitomycin C

β-styrenesulfonyl chloride
4091-26-3

β-styrenesulfonyl chloride

<1aS-(1a4a,8β,8aα,8bα)>-6-amino-8-<<(aminocarbonyl)oxy>methyl>-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methyl-1-(styryl)sulfonylazilidino<2',3':3,4>pyrrolo<1,2-a>indole-4,7-dione

<1aS-(1a4a,8β,8aα,8bα)>-6-amino-8-<<(aminocarbonyl)oxy>methyl>-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methyl-1-(styryl)sulfonylazilidino<2',3':3,4>pyrrolo<1,2-a>indole-4,7-dione

Conditions
ConditionsYield
With pyridine for 1.5h; Ambient temperature;77%
mitomycin C
50-07-7

mitomycin C

phenyl isothiocyanate
103-72-0

phenyl isothiocyanate

7-amino-9a-methoxy-1a-(phenylthiocarbamoyl)mitosane
18887-04-2

7-amino-9a-methoxy-1a-(phenylthiocarbamoyl)mitosane

Conditions
ConditionsYield
In 1,2-dimethoxyethane for 6.5h; Heating;73%
mitomycin C
50-07-7

mitomycin C

p-toluenesulfonyl chloride
98-59-9

p-toluenesulfonyl chloride

N(1a)-(toluenesulfonyl)mitomycin C
5091-32-7

N(1a)-(toluenesulfonyl)mitomycin C

Conditions
ConditionsYield
With pyridine; triethylamine at 0℃; for 0.333333h;70%
mitomycin C
50-07-7

mitomycin C

2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl isothiocyanate
14152-97-7

2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl isothiocyanate

N-(tetra-O-acetylglucopyranosyl)-1a-mitomycin C carbothioamide
132059-46-2

N-(tetra-O-acetylglucopyranosyl)-1a-mitomycin C carbothioamide

Conditions
ConditionsYield
In tetrahydrofuran Ambient temperature;65%
mitomycin C
50-07-7

mitomycin C

N,N-dimethyl-formamide dimethyl acetal
4637-24-5

N,N-dimethyl-formamide dimethyl acetal

7-amino-N10-<(dimethylamino)methylene>-9a-methoxymitosane
88948-99-6

7-amino-N10-<(dimethylamino)methylene>-9a-methoxymitosane

Conditions
ConditionsYield
In methanol; chloroform at 50℃; for 0.833333h;64%
mitomycin C
50-07-7

mitomycin C

A

cis-1-hydroxy-2-acetamido-7-aminomitosene
54911-22-7

cis-1-hydroxy-2-acetamido-7-aminomitosene

B

2β,7-Diamino-1α-hydroxymitosene
99745-88-7

2β,7-Diamino-1α-hydroxymitosene

C

2β,7-Diamino-1β-hydroxymitosene
98462-75-0

2β,7-Diamino-1β-hydroxymitosene

D

2,7-Diaminomitosene
92695-32-4

2,7-Diaminomitosene

Conditions
ConditionsYield
With Tris-HOAc-buffer pH 5.50; 4-methoxyphenylhydrazine hydrochloride In water for 48h; Mechanism; Ambient temperature; other substrates, also with D2O;A n/a
B n/a
C n/a
D 63%
With Tris-HOAc-buffer pH 5.50; 4-methoxyphenylhydrazine hydrochloride In water for 48h; Ambient temperature;A n/a
B n/a
C n/a
D 63%
mitomycin C
50-07-7

mitomycin C

N-allyl isothiocyanate
57-06-7

N-allyl isothiocyanate

<1aS-(1aα,8β,8aα,8bα)>-1-(allylamino)thiocarbonyl-6-amino-8-<<(aminocarbonyl)oxy>methyl>-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methylazilidino<2',3':3,4>pyrrolo<1,2-a>indole-4,7-dione

<1aS-(1aα,8β,8aα,8bα)>-1-(allylamino)thiocarbonyl-6-amino-8-<<(aminocarbonyl)oxy>methyl>-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methylazilidino<2',3':3,4>pyrrolo<1,2-a>indole-4,7-dione

Conditions
ConditionsYield
With pyridine; benzotriazol-1-ol for 18h; Ambient temperature;62%

Mitomycin C Chemical Properties

Product Name: Mitomycin C
Synonyms: (1aS,8S,8aR,8bS)-6-Amino-8a-methoxy-5-methyl-4,7-dioxo-1,1a,2,4,7,8,8a,8b-octahydroazireno[2',3':3,4]pyrrolo[1,2-a]indol-8-yl]methyl carbamate ; [(1aS,8S,8aR,8bS)-6-Amino-8a-methoxy-5-methyl-4,7-dioxo-1,1a,2,4,7,8,8a,8b-octahydroazireno[2',3':3,4]pyrrolo[1,2-a]indol-8-yl]methylcarbamat ; [1aS-(1aa,8b,8aa,8ba)]-6-Amino-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methylazirino[2',3':3,4]pyrrolo[1,2-a]indole-4,7-dione ; Azirino[2',3':3,4]pyrrolo[1,2-a]indole-4,7-dione, 6-amino-1,1a,2,8,8a,8b-hexahydro-8-[(hydroxyiminomethoxy)methyl]-8a-methoxy-5-methyl-, (1aS,8S,8aR,8bS)- ;azirino[2',3':3,4]pyrrolo[1,2-a]indole-4,7-dione, 6-amino-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methyl-, (1aS,8S,8aR,8bS)- ;carbamate de [(1aS,8S,8aR,8bS)-6-amino-8a-méthoxy-5-méthyl-4,7-dioxo-1,1a,2,4,7,8,8a,8b-octahydroaziréno[2',3':3,4]pyrrolo[1,2-a]indol-8-yl]méthyle ;MitoExtra ;Mito-medac ;Mitomycin C derivative ;Mitomycin derivative
Product Categories: Antibiotics;Antibiotic Explorer;Intermediates & Fine Chemicals;Pharmaceuticals;Antibiotics G-MAntibiotics;AntibioticsStem Cell Expansion;AziridinesStem Cell Biology;DissociationAntibiotics;Interferes with DNA SynthesisMore...Close...;Antibiotics A to;Antibiotics by Application;AntibioticsAntibiotics;Antineoplastic and Immunosuppressive AntibioticsAntibiotics;Cell Culture;Chemical Structure Class;Culture;Mechanism of Action;Reagents and Supplements;Stem Cell Isolation;AziridinesAntibiotics;Core Bioreagents;Interferes with DNA Synthesis;Research Essentials
Molecular Structure:
Molecular Formula : C15H18N4O5
Molecular Weight: 334.33
CAS NO: 50-07-7
EINECS : 200-008-6
Merck : 13,6236
Index of Refraction: 1.68
Surface Tension: 77.2 dyne/cm
Density: 1.56 g/cm3
Flash Point: 305.6 °C
Enthalpy of Vaporization: 86.99 kJ/mol
Boiling Point: 581.8 °C at 760 mmHg
Vapour Pressure: 1.59E-13 mmHg at 25°C
Melting point : 360 ºC
Water solubility : soluble
Storage temp. 2-8°C
Solubility H2O: 4 mL/vial Stock solutions should be filter sterilized and stored at 2-8 °C in the dark., clear to slightly hazy, blue to purple
Stability: Stable. Incompatible with strong acids, strong bases, strong oxidizing agents.
Blue-Violet Crystals
 

Mitomycin C Uses

 Mitomycin C (CAS NO.50-07-7) is an antitumor antibiotic.

Mitomycin C Production

 Raw materials :Dichloromethane-->streptomyces avermifilis
 Mitomycin C (CAS NO.50-07-7) is obtained by the separation and purification of inoculum of the soil actinomycete strain .

Mitomycin C Toxicity Data With Reference

 

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
bird - wild LD50 oral 7500ug/kg (7.5mg/kg)   Archives of Environmental Contamination and Toxicology. Vol. 12, Pg. 355, 1983.
 
cat LDLo intravenous 2500ug/kg (2.5mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BEHAVIORAL: ATAXIA

GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"
Cancer Research. Vol. 20, Pg. 1354, 1960.
 
dog LD50 intravenous 720ug/kg (0.72mg/kg)   Drugs in Japan Vol. -, Pg. 1129, 1990.
man TDLo unreported 1350ug/kg/21W (1.35mg/kg) KIDNEY, URETER, AND BLADDER: "CHANGES IN TUBULES (INCLUDING ACUTE RENAL FAILURE, ACUTE TUBULAR NECROSIS)"

BLOOD: NORMOCYTIC ANEMIA
Archives of Internal Medicine. Vol. 143, Pg. 803, 1983.
 
monkey LDLo intravenous 1mg/kg (1mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BLOOD: HEMORRHAGE

GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"
Cancer Research. Vol. 20, Pg. 1354, 1960.
 
mouse LD50 intraperitoneal 4mg/kg (4mg/kg)   Journal of Antibiotics, Series A. Vol. 13, Pg. 27, 1960.
mouse LD50 intravenous 4mg/kg (4mg/kg)   Journal of Antibiotics, Series A. Vol. 13, Pg. 27, 1960.
mouse LD50 oral 23mg/kg (23mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"
Cancer Research. Vol. 20, Pg. 1354, 1960.
 
mouse LD50 subcutaneous 7300ug/kg (7.3mg/kg)   Japanese Journal of Cancer Research. Vol. 80, Pg. 670, 1989.
 
mouse LD50 unreported 12mg/kg (12mg/kg)   Cancer Research. Vol. 46, Pg. 2703, 1986.
 
mouse LDLo intratracheal 4mg/kg (4mg/kg)   Toxicology Letters. Vol. 30, Pg. 63, 1986.
 
quail LD50 oral > 100mg/kg (100mg/kg)   Ecotoxicology and Environmental Safety. Vol. 6, Pg. 149, 1982.
rabbit LD50 intravenous 3400ug/kg (3.4mg/kg)   Drugs in Japan Vol. -, Pg. 1129, 1990.
rat LD50 intraperitoneal 2mg/kg (2mg/kg)   Advances in Teratology. Vol. 3, Pg. 181, 1968.
rat LD50 intravenous 3mg/kg (3mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 20, Pg. 1467, 1970.
 
rat LD50 oral 30mg/kg (30mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"
Cancer Research. Vol. 20, Pg. 1354, 1960.
 
rat LD50 subcutaneous 3250ug/kg (3.25mg/kg)   Drugs in Japan Vol. 6, Pg. 798, 1982.
women TDLo intravenous 1800ug/kg (1.8mg/kg) LUNGS, THORAX, OR RESPIRATION: FIBROSING ALVEOLITIS

LUNGS, THORAX, OR RESPIRATION: DYSPNEA
Lancet. Vol. 2, Pg. 1037, 1980.
women TDLo unreported 2100ug/kg/40W (2.1mg/kg) BLOOD: OTHER HEMOLYSIS WITH OR WITHOUT ANEMIA

BLOOD: OTHER CHANGES
Archives of Internal Medicine. Vol. 143, Pg. 1617, 1983.
 

Mitomycin C Safety Profile

 Hazard Codes T,T+,Xn
Risk Statements 25-40-22-45-26/27/28
R25 :Toxic if swallowed.
R40:Limited evidence of a carcinogenic effect.
R22:Harmful if swallowed.
R45:May cause cancer.
R26/27/28:Very toxic by inhalation, in contact with skin and if swallowed.
Safety Statements 36/37-45-28-53-22
S36/37:Wear suitable protective clothing and gloves.
S45:In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.)
S28:After contact with skin, wash immediately with plenty of soap-suds.
S53:Avoid exposure - obtain special instructions before use.
S22:Do not breathe dust.
RIDADR UN 3462 6.1/PG 2
WGK Germany 3
RTECS CN0700000
F 8-10
HazardClass 6.1(a)
PackingGroup II

Mitomycin C Specification

1.General Description :Blue-violet crystals. Used as an anti-tumor antibiotic complex.
2.Air & Water Reactions :Water soluble.
3.Reactivity Profile: Mitomycin C is sensitive to prolonged exposure to light. Mitomycin C may be sensitive to prolonged exposure to air. Mitomycin C is incompatible with strong oxidizing agents, strong acids and strong bases. Calcium salts may cause decomposition.
4.Health Hazard: Toxic doses as low as 750 mg/kg have been reported in humans. The major toxic effect is myelosuppression, characterized by marked leukopenia and thrombocytopenia; this may be delayed and cumulative. Interstitial pneumonia and glomerular damage resulting in kidney failure are unusual but well documented complications. Lung conditions -- administration of mitomycin has been recognized as causing pneumonitis, alveolitis and pulmonary fibrosis. Kidney conditions -- administration of Mitomycin Can cause kidney damage. Kidney toxicity was observed in 1-5 percent of patients. Depressed immune conditions.
5.Fire Hazard :Flash point data for Mitomycin C are not available; however, Mitomycin C is probably combustible.

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View